Company Overview

Update
Headquarters:
Amsterdam
Funding:
$6M

myTomorrows is a Dutch startup that wants to disrupt the way patients with unmet medical needs access to development-stage treatments —

Description

Update

myTomorrows is a Dutch startup that wants to disrupt the way patients with unmet medical needs access to development-stage treatments — drugs that are still undergoing clinical trials and working there way through a lengthy regulatory approval process. It targets patients who are typically up against time (e.g. specific types of cancer) and for whom drugs that could prolong or improve their quality of life do sometimes exist but aren’t yet “approved” and readily available on the market, even though positive trials have been conducted. Right now, how a patient accesses these treatments is somewhat of a lottery, if they can access them at all. By providing a platform that connects patients, doctors and drugs companies, myTomorrows wants to change that.

Funding Rounds (2) - $6M

Update
  • $2.20M

    Investors Unknown
    Feb 19, 2014 -Unknown
  • $3.80M

    Investors Unknown
    2012 -Unknown

Offices/Locations (1)

Update
  • Office

    Pilotenstraat 45

    Amsterdam, 1059 CH

    ANT

Images (1)

Update
  • 0cf49eb73b77251ebf408886485362d0